SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC

Clinical trial NCT06989671 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06989671
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2025-08-30
Primary completion: 2027-12-30
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.